Newsroom Categories: Press release

  • McDermott Supercharges Energy Transactions Market with Texas-Based Private Equity and M&A-Focused Duo

    McDermott Supercharges Energy Transactions Market with Texas-Based Private Equity and M&A-Focused Duo

    PRESS RELEASE

    McDermott Supercharges Energy Transactions Market with Texas-Based Private Equity and M&A-Focused Duo

    March 3, 2021

    Read time: 5 min

    International law firm McDermott Will & Emery announced that Jack Langlois and Jibin Luke have joined the Transactions Practice Group as partners based in the Houston office. These hires diversify our robust energy practice and add strength in a geographically critical area as clients weigh business opportunities with potential federal energy regulations on the horizon. Jack and Jibin both join from DLA Piper where Jack served as US co-chair of the firm’s energy sector and managing partner in Houston.

    “Jack is a high-profile dealmaker known in the Texas energy and legal circles, and we’re thrilled to welcome him and Jibin to McDermott. This group will provide clients a direct connection to the United States’ largest economic hub for oil and gas, paving the way for additional mergers and acquisitions and private equity deals,” Harris Siskind, global head of McDermott’s transactions practice group, said. “With this added expertise, we’re advancing our already high-impact, high-volume deal activity while diversifying our fast-growing energy practice. Our broader platform will make McDermott a destination firm for clients’ energy-related transactional and regulatory needs.”

    “It’s clear that McDermott is an elite global firm in terms of clients, significant engagements and financial results, while prioritizing a great emphasis on fostering a collaborative environment—it is deeply woven into the culture and sets it apart from other firms,” Jack added. “Add this to an imperative to grow and diversify energy offerings in the US and around the world, and it’s an ideal fit for our group and our clients, as well as other lawyers in the Texas market desiring a successful platform [for themselves and their clients].”

    Head of Strategy Michael Poulos noted, “Texas in general and Houston in particular is one of the leading markets in the legal industry, and we are very excited by our continued trajectory and growth in the market. From a client offering perspective, Jack and Jibin complement and diversify an already vibrant energy sector offering at the Firm – this made the decision to have them join us an easy one.”

    Jack advises clients on investments in and financings of energy projects and assets, including mergers, joint ventures and acquisitions and dispositions of assets and stock of energy companies. Jack advises on mineral exploration and development projects, involving acquisition of exploration and development rights, pipelines, gathering, transportation, processing, storage and other infrastructure. He also represents oil and gas production companies in connection with the acquisition of oil and gas properties; and banks in connection with production payment acquisition and financing. Jack has significant experience handling international transactions, including representing drilling companies in connection with sales of drilling rigs in Brazil, Canada and Greece, and representing power producers with the development and financing of power projects in Latin America.

    Jibin represents business owners and investors with structuring and negotiating mergers and acquisitions, leveraged buyouts, energy transactions, equity investments and other general corporate matters. He regularly advises clients on domestic and international transactions, corporate governance matters, private debt and equity financing, regulatory matters and portfolio company investments. Jibin represents clients in the acquisition and sale of energy, manufacturing, technology and service-related companies, and negotiating and securing financing. He has experience preparing and negotiating purchase and sale agreements, joint venture agreements, joint operating agreements, partnership agreements, limited liability company agreements, transportation and gathering agreements, employment and consulting agreements, credit and security agreements and master service agreements.

    With the energy market poised for growth, McDermott has bolstered our renewable and conventional energy practices globally. Notable partner hires over the last year include Carl Fleming, Christopher Gladbach, Neil Levy, Bruce Richardson and David Tewksbury in Washington, DC; Lloyd MacNeil and Edward Zaelke in Los Angeles; and Shashank Krishna in London.

    This group further supports the Firm’s growing private equity (PE) deal volume, building momentum on more than 360 deals closed in 2020. McDermott was recently ranked by Pitchbook in its 2020 league tables as #3 in PE in the US and #5 in PE globally.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Carl J. Fleming

    Partner

    Washington, DC

    Christopher Gladbach

    Partner

    Washington, DC

    Neil L. Levy

    Partner

    Washington, DC

    David G. Tewksbury

    Partner

    Washington, DC

    Edward Zaelke

    Partner

    Los Angeles

    You may also like

  • What’s Next For Healthcare Private Equity?

    What’s Next For Healthcare Private Equity?

    PRESS RELEASE

    What’s Next For Healthcare Private Equity?

    March 3, 2021

    Read time: 4 min

    Leading health law firm McDermott Will & Emery is hosting its annual HPE Miami Conference on March 9-12, 2021, with four days of virtual sessions where private equity investors and industry experts will delve into the insights and strategies shaping the future of healthcare investing.

    “This is a game-changing time for healthcare private equity and we’re incredibly excited to see the deals that are already taking shape this year,” said Ira Coleman, Chairman of McDermott Will & Emery. “HPE Miami has always brought focused, leading-edge insights from among the industry’s biggest hitters. As leaders plan their next strategic moves, these perspectives have never been more important.”

    Conference speakers include some of the most important healthcare organizations and leaders across industry subsectors. Among several, we are pleased to welcome Miriam Tawil, Managing Director of Centerbridge Partners; Dr. Richard Park, Founding CEO of CityMD; Megan Preiner, Managing Director of Thomas H. Lee Partners; and Slava Girzhel, US Head of Health Care Investment Banking, Senior Managing Director, Ernst & Young Capital Advisors.

    Sessions include:

    MISSION CRITICAL: ACTION PLANS FOR OPTIMIZING YOUR HEALTHCARE
    March 9, 11:00–1:00 EST

    Strategies for investments, including considerations for contingent purchase pricing; benefits and limits of Representation & Warranty insurance for healthcare risks; critical tactics for combining two platforms in one sector; and regulatory and government enforcement trends.

    SUBSECTOR INSIGHTS: WHAT’S AROUND THE CORNER?
    March 10, 11:00– 2:00 EST

    Top-tier investment professionals, executives and bankers consider some of the hottest health industry subsectors today, including behavioral health, dermatology, dental, GI, hospice/ home care, ophthalmology, orthopedics, pharma services, pharmacy, urgent care, urology and women’s care.

    STAYING AHEAD OF THE CURVE: HPE’S MOST IMPORTANT TRENDS
    March 11, 11:00– 1:00 EST

    Examines the proliferation of risk-based/value-based businesses; selling healthcare portfolio companies to SPACs; alliances between private equity/ hospitals and health systems; and best practices to properly and profitably integrate telehealth into portfolio companies.

    THE BIG PICTURE: TODAY’S TRENDS AND FUTURE OUTLOOK
    March 12, 11:00– 1:30 EST

    Managing directors, investment bankers, and finance and lending executives provide valuable insights on distressed health investing, the current market and where the industry is heading.

    Media are invited to attend the event. To register as media, contact Kerri Chace at kchace@mwe.com. Visit the conference webpage for more information.

    McDermott Will & Emery is the nation’s leading health law firm. The Health Industry Advisory group is the only health practice to receive top national rankings from U.S. News – Best Lawyers “Best Law Firms,” Chambers USA, The Legal 500 US, and Law360. PitchBook recently recognized McDermott as the most active firm in healthcare private equity for the fourth consecutive year, handling 41 more healthcare private equity transactions in 2020 than its nearest competitor.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Ira J. Coleman

    Chairman

    Miami

    You may also like

  • The History of the 1921 Tulsa Race Massacre and Today’s Groundbreaking Litigation

    The History of the 1921 Tulsa Race Massacre and Today’s Groundbreaking Litigation

    PRESS RELEASE

    Blank Media template

    Read time: 2 min

    About Us
    You may also like

  • Schulte Advises Bardin Hill Investment Partners on Formation of Bardin Hill Opportunistic Credit Fund

    Schulte Advises Bardin Hill Investment Partners on Formation of Bardin Hill Opportunistic Credit Fund

    PRESS RELEASE

    Schulte Advises Bardin Hill Investment Partners on Formation of Bardin Hill Opportunistic Credit Fund

    March 2021

    Read time: 3 min

    Schulte advised Bardin Hill Investment Partners LP on the formation of Bardin Hill Opportunistic Credit Fund LP and its parallel side-car vehicle (“the Fund”) to pursue the firm’s flagship closed-end strategy. The Fund had a final closing in February 2021 with commitments totaling approximately $600 million. The Fund is focused on credit strategies and identifies and executes on stressed, distressed, process-driven and special situations investments less correlated to global debt and equity markets with a focus on control-oriented opportunities in smaller and medium-sized capital structures. The Fund received significant backing from new institutional investors globally, as well as from existing Bardin Hill clients, and leverages Bardin Hill’s extensive experience investing across multiple market cycles and niche credit strategies to maximize returns for investors while mitigating downside risk.

    Bardin Hill is a global investment management firm specializing in credit strategies and event driven equities with approximately $8.4 billion in assets under management.

    The Schulte team advising Bardin Hill was led by investment management partners Jason Kaplan and Heather Wyckoff. The team also included investment management associate David Weintraub; tax partners Philippe Benedict and David Griffel and tax associate Olesia Zakon; finance & derivatives partner Daniel Oshinsky and associate Farzaan Ijaz; employment & employee benefits partner David Cohen; and former Schulte lawyers Talia Jaffe and Theresa Tran.

    About Us

    Jason S. Kaplan

    Partner

    New York – 919 Third Avenue

    Philippe Benedict

    Partner

    New York – 919 Third Avenue

    David S. Griffel

    Partner

    New York – 919 Third Avenue

    Daniel V. Oshinsky

    Partner

    New York – 919 Third Avenue

    David M. Cohen

    Partner

    New York – 919 Third Avenue

    You may also like

  • McDermott Expands Restructuring Practice in Atlanta to Meet Growing Client Demand

    McDermott Expands Restructuring Practice in Atlanta to Meet Growing Client Demand

    PRESS RELEASE

    McDermott Expands Restructuring Practice in Atlanta to Meet Growing Client Demand

    March 2, 2021

    Read time: 4 min

    International law firm McDermott Will & Emery is pleased to announce the arrival of Atlanta-based partner Daniel (Dan) M. Simon to the Firm’s Restructuring and Insolvency practice. Dan is the latest addition to our growing Atlanta office, and to our rapidly expanding restructuring team. Dan joins the Firm from DLA Piper.

    “Dan is a terrific lawyer with the institutional knowledge to quickly assess clients’ restructuring goals and leverage opportunities to drive results,” Felicia Perlman, global co-head of the Firm’s Restructuring and Insolvency Practice Group, said. “We’re pleased to add Dan to our growing restructuring team and know that our clients will instantly benefit from his veteran presence in the booming Atlanta market. His background advising on distressed healthcare and food and beverage matters also aligns with McDermott’s industry expertise, providing our clients with an even greater competitive advantage in these sectors.”

    “It’s rare that you find a firm with such a strong growth trajectory and a truly healthy culture,” Dan added. “I know my clients will benefit immediately from both the industry-leading experience and the passion and commitment of the lawyers on the McDermott platform as they look to capitalize on opportunities in the recovering global economy. I am excited to help build on the vision and brand of the Firm, and to help assist our clients navigate distressed transactions.”

    Dan focuses his practice on corporate restructuring and bankruptcy and represents clients in the healthcare, restaurant, transportation, technology and other industries. He counsels clients on strategic alternatives, corporate transactions and general corporate matters to best position them during distressed periods. He protects and advances the interests of distressed companies and parties seeking to purchase distressed assets in commercial workouts and Chapter 11 reorganization cases. Dan also assists clients with all aspects of Chapter 11 proceedings, including sales of assets pursuant to Section 363 of the Bankruptcy Code, confirmation of plans of reorganization, resolution of claims and prosecution and defense of various adversary proceedings.

    Dan received his JD from Duke University School of Law and his BA from Vanderbilt University.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Daniel M. Simon

    Partner

    Atlanta

    You may also like

  • McDermott Advises Biotech Specialist Diagenode on its Sale to US Women’s Health Giant Hologic

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Advises Biotech Specialist Diagenode on its Sale to US Women’s Health Giant Hologic

    March 2, 2021

    Read time: 3 min

    McDermott Will & Emery advised Diagenode on its sale to US women’s health giant Hologic (Nasdaq: HOLX). Diagenode is a Liège-based biotech company specializing in the development of molecular diagnostic tests

    This acquisition will make the Belgian company “the central focus for the manufacture, research and distribution in Europe” for the American group, a partner of Diagenode since 2016.

    The purchase price reached $159 million, or approximately 130 million euros. The shareholders of the Liège-based company include its founder and CEO, Didier Allaer, as well as the Noshaq investment fund (formerly Meusinvest) and the Epimède capital fund.

    Diagenode offers more than 30 real-time PCR assays for the detection of bacteria, parasites and viruses. It reached a turnover of 25 million euros in 2020.

    In this transaction, McDermott Will & Emery advised Diagenode with a team composed of:

    • Henri Pieyre de Mandiargues, Anthony Paronneau, partners (Paris), David Lipkin partner (Silicon Valley), Emmanuelle Turek and Sofiya Kachan associates (Paris), in corporate
    • Antoine Vergnat, partner and Côme de Saint Vincent, associate, in tax (Paris)

    Weil Gotshal & Manges advised Hologic in the US, assisted by Stibbe in Belgium.

    The Mosal law firm also advised Diagenode on aspects of Belgian law.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    David A. Lipkin

    Counsel

    Silicon Valley

    Antoine Vergnat

    Partner

    Paris

    You may also like

  • McDermott Advises Unsere Champions on Add-On Acquisition of Montessori Kinderhaus

    McDermott Advises Unsere Champions on Add-On Acquisition of Montessori Kinderhaus

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Advises Unsere Champions on Add-On Acquisition of Montessori Kinderhaus

    March 2, 2021

    Read time: 3 min

    Frankfurt, 1 March 2021 – McDermott Will & Emery advised Unsere Champions GmbH on the acquisition of “Montessori Kinderhaus” kindergarten in Ludwigsburg, Germany. The seller is Bettina Wörsinger, head of Montessori Kinderhaus.

    The rapidly growing Unsere Champions GmbH operates kindergartens and nursery schools in 20 cities in Bavaria and Baden-Württemberg. The majority shareholders of Unsere Champions are French Enjoy Group and Luxembourg-based Lavorel Group.

    McDermott regularly advises Unsere Champions on transactions, including the acquisition of Kleine Bärchen, Isarkids Group, Child Care Company, Zwergenwelt and MD KitaPartner.

    The McDermott team was led by Norman Wasse and included Maximilian Clostermeyer as well as associates Marion von Grönheim, Victoria Huf and Elena Platte.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    You may also like

  • McDermott Comment | High Yield Market Developments In Europe And The US

    McDermott Comment | High Yield Market Developments In Europe And The US

    PRESS RELEASE

    McDermott Comment | High Yield Market Developments In Europe And The US

    March 1, 2021

    Read time: 3 min

    Mark Fine, partner at law firm McDermott Will & Emery, said:

    “The market trends in 2021 such as unprecedented government and central bank support coupled with investor demand and low borrowing costs have led to a huge swell of primary issuances this year. Both the high yield and leverage loan markets, to date, have been operating somewhat in contrast to the macro reality across Europe. With the US 10 year bond rallying and having a knock on effect to the equity markets, it is not surprising, that there are some early signs of jitters in the market. This combined with increased talk of inflation may now lead to a slight cooling off period in the high yield and leverage loan markets. As the earning’s season continues we may well see the secondary market beginning to open up again albeit, given what we saw last year, it is not clear for how long.”

    Ranajoy Basu, partner at law firm McDermott Will & Emery, added:

    “While there seems to be indications of price adjustments following the tremendous push for issuances since the start of the year, there still are very strong signs when one considers the pipeline of transactions coming through to suggest that the market will be resilient and that there is momentum for issuers, at least in the European high yield markets. This certainly holds true for numerous issuances that are being structured from refinancing or broader restructuring purposes. Corporate Trustees have also seen an extremely busy period with both “new money” issuances and refinancing of existing high yields.”

    About Us

    Mark Fine

    Partner

    London – 22 Bishopsgate

    You may also like

  • McDermott Advises Eight Roads on the Sale of Leading European Ophthalmology Chain Optegra

    McDermott Advises Eight Roads on the Sale of Leading European Ophthalmology Chain Optegra

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Advises Eight Roads on the Sale of Leading European Ophthalmology Chain Optegra

    February 26, 2021

    Read time: 5 min

    LONDON – 26 February 2021 – McDermott Will and Emery advised Eight Roads  in relation to the sale of the Optegra Group to H2 Equity Partners.

    The Optegra Group is a leading pan-European ophthalmology group comprising 23 eye hospitals and clinics in the United Kingdom, Czech Republic (where trading as Lexum) and Poland. Optegra provides a range of critical eye-care services including cataract surgeries and AMD as well as leading innovative vision correction procedures. The business provides leading eye-care to publicly funded national healthcare systems such as the NHS as well as to self-pay patients. The group holds top-3 market positions in each of the countries in which it operates.

    Optegra runs nine hospitals and clinics in the UK, many of them in prime locations such as London’s Harley Street, and has a network of nine branches across Poland, whilst the Czech-based Lexum is one of the largest and most sought after European eye clinics.

    Eight Roads is a global proprietary investment firm backed by Fidelity. It has 50 years of investment experience partnering with ambitious technology and healthcare founders from all across the world. Eight Roads has a global portfolio of over 250 companies and investment teams across Asia, Europe and the US. H2 Equity Partners, founded in 1991, is a leading Western European hands-on investment firm focusing on the United Kingdom, Ireland and the Benelux. H2 Equity Partners is an entrepreneurial and hands-on investment company investing in mid-sized companies with significant growth or improvement potential.

    William Blair acted as financial advisor to the seller.

    Eversheds Sutherland acted as legal advisor to the buyer.

    The McDermott cross practice team was led by London Private Equity partner Tom Whelan and senior associate Elisa de Carolis, supported by partner Sharon Lamb  and associate Bella North (Health), partner Ashley Winton and associate Sophie Wood (Data Protection), partner Tom Calnan and associate Rose McSwiney (Real Estate), senior associate Sarah Gabbai (Tax) and associates Rosie Mist (Corporate) and Chris Lynn (Employment).

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Sharon Lamb

    Partner

    London – 22 Bishopsgate

    Bella North

    Senior Associate

    London – 22 Bishopsgate

    Rosemary Tulloch

    Senior Associate

    London – 22 Bishopsgate

    You may also like

  • McDermott Comment | EG Group To Raise Extra $1.8bn Debt To Buy Asda Petrol Stations

    McDermott Comment | EG Group To Raise Extra $1.8bn Debt To Buy Asda Petrol Stations

    PRESS RELEASE

    McDermott Comment | EG Group To Raise Extra $1.8bn Debt To Buy Asda Petrol Stations

    February 26, 2021

    Read time: 2 min

    Aymen Mahmoud, partner at law firm McDermott Will & Emery, said:

    “This acquisition by the EG Group of an accretive and synergistic business line is emblematic of a key private equity trend. The acquisition and integration of multiple businesses into existing portfolio groups in a ‘buy-and-build’ strategy allows private equity to drive significant efficiencies, synergies and cost-savings to increase profitability and drive a return to their investors.

    This approach not only allows a group to build profitability and increase any potential sale price later down the line, but it also allows for the divestment of non-core operations where it is possible to apply greater focus to more profitable business lines.”

    About Us

    Aymen Mahmoud

    Partner

    London – 22 Bishopsgate

    You may also like